United States · Series B startup

Who invested in MedTrainer

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Regtech

Funding summaryUpdated 26 Oct 2026

$43Mraised across 1 round since 2022, from 1 source

Latest round
Series B, $43MApr 2022
Investors
1
See who backed them

The rounds

  1. Apr 2022
    Series B$43M

    Source recorded

Founders and team

From MedTrainer's own website and the SEC filings it signed: 2 founders, 9 on the team.

Steve GallionChief Executive Officer & Co-FounderNamed on its 2019 Form D
Jorge FernandezCo-Founder
  • Mariano RenteriaSenior Vice President of Engineering
  • Erika GotliebChief Client Officer
  • Jamie OakesChief Revenue Officer
  • Rishi PatelChief Financial Officer
  • Ted GottisChief Human Resources Officer
  • Todd ScottChief Technology Officer
  • Vince KoehlerChief Marketing Officer
  • Brian WilliamsVP of Compliance
  • Hira RashidDirector of Learning

Everyone who backed them

Vista Equity PartnersPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about MedTrainer

Who invested in MedTrainer?

MedTrainer's investors include Vista Equity Partners.

How much has MedTrainer raised?

MedTrainer has raised $43M across 1 round since 2022.

When did MedTrainer last raise?

MedTrainer's most recent round was a Series B of $43M in Apr 2022.

What was MedTrainer's biggest round?

Its most recent round, $43M in Apr 2022, is also its largest on record.

Who backed MedTrainer first?

MedTrainer's first round on record, in Apr 2022, was backed by Vista Equity Partners.

What stage is MedTrainer at?

MedTrainer's latest named round is a Series B, in Apr 2022.

Where is MedTrainer based?

MedTrainer is based in the United States.

Companies like MedTrainer

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.